[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341924-105":59,"doc-detail-341924-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","homologous-recombination-deficiency-gene-panel-analysis-results-in-synchronous-endometrial-and-ovarian-cancers","Homologous recombination deficiency gene panel analysis results in synchronous endometrial and ovarian cancers","","Objective: Analyze genetic alterations from a homologous recombination deficiency gene panel in patients diagnosed with synchronous endometrial ovarian cancer (SEOC) and followed for over 5 years using next-generation sequencing. Methods: DNA extracted from formalin-fixed, paraffin-embedded tissue blocks; Illumina capture-based sequencing with the Sophia HR Solution DNA Kit. Results: Seven patients included; pathogenic/likely pathogenic somatic mutation ratios varied across endometrium and ovary, with ATM the most common alteration. Conclusion: Pathogenic variations supporting SEOC diagnosis were identified in all but one case, with ATM potentially linked to favorable prognosis.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/homologous-recombination-deficiency-gene-panel-analysis-results-in-synchronous-endometrial-and-ovarian-cancers/341924/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/homologous-recombination-deficiency-gene-panel-analysis-results-in-synchronous-endometrial-and-ovarian-cancers/341924.png","ImageObject",300,407,{"name":92,"@type":93},"Rowan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the main objective of the study?","Question",{"text":113,"@type":114},"To analyze genetic alterations in SEOC patients using a homologous recombination deficiency gene panel through next-generation sequencing.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were genetic alterations analyzed in the patients?",{"text":118,"@type":114},"DNA was isolated from formalin-fixed, paraffin-embedded tissue blocks and sequenced using Illumina capture-based next-generation sequencing with the Sophia HR Solution DNA Kit.",{"name":120,"@type":111,"acceptedAnswer":121},"Which gene alteration was most common, and what was its proposed implication?",{"text":122,"@type":114},"ATM gene mutations were the most common alteration and may be associated with a favorable prognosis.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},341924,1790859790,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","ORIGINAL ARTICLE  \n[https://doi.org/10.1590/1806-9282.20240534](https://doi.org/10.1590/1806-9282.20240534)  \nHomologous recombination deficiency gene panel analysis results in synchronous endometrial and ovarian cancers  \nFerah Kazanci1* , Zerrin Yılmaz Çelik2 , Mert Polat2 , Ferhat Karademir3 , Ozlem Erdem4 , Feride İffet Şahin2 , Mehmet Anil Onan1   \nSUMMARY  \nOBJECTIVE: The objective of this study was to analyze the genetic alterations of tumors within the scope of the homologous recombination deficiency gene panel inpatients diagnosed with synchronous endometrial ovarian cancer who have been followed for over 5 years using next-generation sequencing. METHODS: DNA was isolated from the patient’s formalin-fixed, paraffin-embedded tissue blocks. Next-generation sequencing was performed using the Illumina capture-based sequencing method. Samples were sequenced using the Sophia HR Solution DNA Kit.  \nRESULTS: Seven patients were included in this study. The ratios of likely pathogenic (LP)/pathogenic (P) somatic mutations in ATM (serine/threonine kinase or Ataxia-telangiectasia mutated gene), BRCA2 (breast cancer type 2 susceptibility gene), BARD1 (BRCA1 associated RING domain 1), TP53 (tumor protein p53), BIRP1 (BRCA1-interacting helicase 1 gene), PALB2 (partner and localizer of BRCA2), and CHECK2 were 21 (48 . 8%), 8 (18 . 6%), 5 (11 . 6%), 3 (6 . 9%), 2 (4 . 6%), 2 (4 . 6%), and 2 (4 . 6%), respectively, in endometrium, and the ratios of somatic mutations in ATM, BRCA2, TP53, BARD1, RAD54L (DNA repair/recombination protein like), BIRP1, and RAD51D (RAD51 recombinase paralog D) were 24 (60%), 6 (15%), 5 (12 . 5%), 2 (5%), 2 (5%), 1 (2 . 5%), and 1 (2 . 5%), respectively, in ovary. In endometrioid-synchronous endometrial ovarian cancer cases, P/LP mutations were observed in ATM and CHECK2 genes in endometrium and ATM, BRCA2, and TP53 genes in ovary. In two non-endometrioid-synchronous endometrial ovarian cancer cases, CHEK2 (checkpoint kinase 2) mutations were observed in endometrium and ATM and TP53 mutations in ovary, whereas in one case, P/ LP mutations in ATM and TP53 genes were common in both tissues.  \nCONCLUSION: Pathogenic variations confirming the diagnosis of synchronous endometrial ovarian cancer with genetic alterations were identified in all but one case. ATM gene mutation emerged as the most common alteration and has a potential association with a favorable prognosis.  \nKEYWORDS: Synchronous neoplasm. Homologous recombination. Deficiency. ATM. Genes.  \nINTRODUCTION  \nThe most common concurrent malignancies in the female genital system are endometrial (EC) and ovarian tumors (OC), observed in 10% of OC cases and 5% of ECs1. The histopathological criteria have been established to determine whether this condition is metastatic (MC) or synchronous endometrial ovarian cancer (SEOC)2,3 . However, relying solely on histopathological findings to differentiate between SEOC and MC can lead to misstaging, causing potential risks by mismanagement of patients. Given the different prognostic properties of MCsand SEOCs, accurate diagnoses are crucial for determining the treatment2,3 . Detailed histopathological features, along with molecular investigations, are recommended for the diagnosis of SEOCs.  \nClonality analyses through parallel sequencing methods were conducted for the differential diagnosis of MCs and SEOCs, identifying SEOCs exhibiting the same clonality4-6. Mutations in TP53 (tumor protein p53), PTEN (phosphatase and tensin homolog), POLE (DNA polymerase epsilon, catalytic subunit), PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha), KRAS (KRAS proto-oncogene GTPase), ARID1A (AT-rich interaction domain 1A), FGFR2 (fibroblast growth factor receptor 2), and CTNNB1 (catenin beta1) genes, as well as immunohistochemical evaluation of DNA mismatch repair (MMR) protein expression, were performed in SEOCs4-8. MMR deficiency was observed in 28.3% of cases with not significantly associated with s","cbCaiozlUC0zoZA3","https://ap.wps.com/l/cbCaiozlUC0zoZA3","pdf",257144,"English","# SUMMARY\n## OBJECTIVE\n## METHODS\n## RESULTS\n## CONCLUSION\n# INTRODUCTION\n# METHODS","[{\"question\":\"What was the main objective of the study?\",\"answer\":\"To analyze genetic alterations in SEOC patients using a homologous recombination deficiency gene panel through next-generation sequencing.\"},{\"question\":\"How were genetic alterations analyzed in the patients?\",\"answer\":\"DNA was isolated from formalin-fixed, paraffin-embedded tissue blocks and sequenced using Illumina capture-based next-generation sequencing with the Sophia HR Solution DNA Kit.\"},{\"question\":\"Which gene alteration was most common, and what was its proposed implication?\",\"answer\":\"ATM gene mutations were the most common alteration and may be associated with a favorable prognosis.\"}]","Homologous recombination deficiency gene panel analysis results in synchronous endometrial and ovarian cancers | PDF",1790044375,18,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4ef3b283df5a3bf18f624157a67079f1.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5c4952b0ea018338b91fa8c1d2c2e403.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3da789f797adf6e992de10593ca7f06a.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4c8e48940941b4513ab8841dfc83fb0e.webp",980,1306]